Ramon Bosser

Directeur Général chez Origo Biopharma SL

Health Technology

Relations actives

Nom	Sexe	Age	Sociétés liées	Collaboration
Maria do Carme Pampín Casal	M	-	Origo Biopharma SL Origo Biopharma SL BiotechnologyHealth Technology Part of AgomAb Therapeutics NV, Origo Biopharma SL engages in research and development of immunotherapeutic products which are focused on treating health disorders. The company is based in A Coruña, Spain. The Spanish company was founded in 2017 by Maria do Carme Pampín Casal, Julio Castro-Palomino Laria. The CEO is Ramon Bosser. Origo Biopharma was acquired by AgomAb Therapeutics NV on December 15, 2021.	7 ans
Julio Castro-Palomino Laria	M	55	Origo Biopharma SL Origo Biopharma SL BiotechnologyHealth Technology Part of AgomAb Therapeutics NV, Origo Biopharma SL engages in research and development of immunotherapeutic products which are focused on treating health disorders. The company is based in A Coruña, Spain. The Spanish company was founded in 2017 by Maria do Carme Pampín Casal, Julio Castro-Palomino Laria. The CEO is Ramon Bosser. Origo Biopharma was acquired by AgomAb Therapeutics NV on December 15, 2021.	7 ans
Andrea Sáez	M	-	Origo Biopharma SL Origo Biopharma SL BiotechnologyHealth Technology Part of AgomAb Therapeutics NV, Origo Biopharma SL engages in research and development of immunotherapeutic products which are focused on treating health disorders. The company is based in A Coruña, Spain. The Spanish company was founded in 2017 by Maria do Carme Pampín Casal, Julio Castro-Palomino Laria. The CEO is Ramon Bosser. Origo Biopharma was acquired by AgomAb Therapeutics NV on December 15, 2021.	-
Clara Campas-Moya	M	-	Origo Biopharma SL Origo Biopharma SL BiotechnologyHealth Technology Part of AgomAb Therapeutics NV, Origo Biopharma SL engages in research and development of immunotherapeutic products which are focused on treating health disorders. The company is based in A Coruña, Spain. The Spanish company was founded in 2017 by Maria do Carme Pampín Casal, Julio Castro-Palomino Laria. The CEO is Ramon Bosser. Origo Biopharma was acquired by AgomAb Therapeutics NV on December 15, 2021.	-
Yolanda Falcón	F	-	Origo Biopharma SL Origo Biopharma SL BiotechnologyHealth Technology Part of AgomAb Therapeutics NV, Origo Biopharma SL engages in research and development of immunotherapeutic products which are focused on treating health disorders. The company is based in A Coruña, Spain. The Spanish company was founded in 2017 by Maria do Carme Pampín Casal, Julio Castro-Palomino Laria. The CEO is Ramon Bosser. Origo Biopharma was acquired by AgomAb Therapeutics NV on December 15, 2021.	-